Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: a prospective phase ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2003-06

AUTHORS

D L Forrest, K Thompson, V G Dorcas, S H Couban, R Pierce

ABSTRACT

We evaluated 40 patients undergoing high-dose chemo/radiotherapy (HDCT) and hematopoietic stem cell transplantation (HSCT) (allogeneic (22), autologous (18)) to determine the safety and feasibility of administering low molecular weight heparin (LMWH) as hepatic veno-occlusive disease (VOD) prophylaxis. Patients received a once daily subcutaneous injection of dalteparin 2500 anti-Xa i.u. commencing the day prior to starting HDCT, and continuing until day +30 post HSCT or hospital discharge, whichever came first. Dosage adjustments were made for patients developing renal failure. All bleeding episodes were recorded and graded and VOD was diagnosed and graded according to Seattle criteria. At 100 days of follow-up, the overall survival and probability of regimen-related mortality were 85 and 15%, respectively. Nine patients developed VOD. The probability of developing VOD post allogeneic and autologous HSCT was 28% (95% CI, 6-45) and 17% (95% CI, 0-32), respectively. VOD was graded as moderate (n=8) and severe (n=1). VOD resolved in all cases except for one patient who died secondary to severe VOD and multiorgan failure. Clinically significant bleeding episodes occurred in three patients; 24 patients developed minor bleeding not requiring specific therapy. All bleeding episodes resolved. These results suggest that LMWH for VOD prophylaxis is safe with a low incidence of serious bleeding events. Whether it is superior to unfractionated heparin, however, is unknown and should be addressed within the context of a randomized controlled trial. More... »

PAGES

1143

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bmt.1704087

DOI

http://dx.doi.org/10.1038/sj.bmt.1704087

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1038745224

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12796794


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dalteparin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemorrhage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatic Veno-Occlusive Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Injections, Subcutaneous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Safety", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation, Autologous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation, Homologous", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Dalhousie University", 
          "id": "https://www.grid.ac/institutes/grid.55602.34", 
          "name": [
            "The Bone Marrow Transplantation Program of Atlantic Canada, Division of Hematology, Department of Medicine, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Forrest", 
        "givenName": "D L", 
        "id": "sg:person.014626371612.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014626371612.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Dalhousie University", 
          "id": "https://www.grid.ac/institutes/grid.55602.34", 
          "name": [
            "The Bone Marrow Transplantation Program of Atlantic Canada, Division of Hematology, Department of Medicine, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Thompson", 
        "givenName": "K", 
        "id": "sg:person.01063571465.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01063571465.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Dalhousie University", 
          "id": "https://www.grid.ac/institutes/grid.55602.34", 
          "name": [
            "The Bone Marrow Transplantation Program of Atlantic Canada, Division of Hematology, Department of Medicine, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dorcas", 
        "givenName": "V G", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Dalhousie University", 
          "id": "https://www.grid.ac/institutes/grid.55602.34", 
          "name": [
            "The Bone Marrow Transplantation Program of Atlantic Canada, Division of Hematology, Department of Medicine, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Couban", 
        "givenName": "S H", 
        "id": "sg:person.0601741326.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601741326.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Pharmacia Canada, Mississauga, Ont., Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pierce", 
        "givenName": "R", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/hep.1840040121", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001684792"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/bjs.1800750920", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003319436"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2002-04-1216", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003577261"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199505183322003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006959942"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007890-198706000-00020", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011021768"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007890-198706000-00020", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011021768"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2141.1999.01680.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011972675"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1700895", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022546807", 
          "https://doi.org/10.1038/sj.bmt.1700895"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1700895", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022546807", 
          "https://doi.org/10.1038/sj.bmt.1700895"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hep.1840190515", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024503731"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0609.1991.tb01859.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027570453"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.98.15.1575", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030465788"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199603143341102", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033022107"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.1990.tb02583.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039154419"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2001-12-0159", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039448350"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1702717", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041342887", 
          "https://doi.org/10.1038/sj.bmt.1702717"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007890-198712000-00011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046507280"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007890-198712000-00011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046507280"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/01621459.1958.10501452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058299418"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007890-199604150-00014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060275812"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007890-199604150-00014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060275812"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007890-199604150-00014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060275812"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-118-4-199302150-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073697190"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-128-12_part_1-199806150-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073701918"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075452537", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076117384", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076351056", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077047096", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1990.8.10.1699", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078482794"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078733315", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0038-1642757", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079418729"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1988.6.10.1562", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079525316"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082494583", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082764184", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082902670", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083343944", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0022-5347(17)41145-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090323469"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2003-06", 
    "datePublishedReg": "2003-06-01", 
    "description": "We evaluated 40 patients undergoing high-dose chemo/radiotherapy (HDCT) and hematopoietic stem cell transplantation (HSCT) (allogeneic (22), autologous (18)) to determine the safety and feasibility of administering low molecular weight heparin (LMWH) as hepatic veno-occlusive disease (VOD) prophylaxis. Patients received a once daily subcutaneous injection of dalteparin 2500 anti-Xa i.u. commencing the day prior to starting HDCT, and continuing until day +30 post HSCT or hospital discharge, whichever came first. Dosage adjustments were made for patients developing renal failure. All bleeding episodes were recorded and graded and VOD was diagnosed and graded according to Seattle criteria. At 100 days of follow-up, the overall survival and probability of regimen-related mortality were 85 and 15%, respectively. Nine patients developed VOD. The probability of developing VOD post allogeneic and autologous HSCT was 28% (95% CI, 6-45) and 17% (95% CI, 0-32), respectively. VOD was graded as moderate (n=8) and severe (n=1). VOD resolved in all cases except for one patient who died secondary to severe VOD and multiorgan failure. Clinically significant bleeding episodes occurred in three patients; 24 patients developed minor bleeding not requiring specific therapy. All bleeding episodes resolved. These results suggest that LMWH for VOD prophylaxis is safe with a low incidence of serious bleeding events. Whether it is superior to unfractionated heparin, however, is unknown and should be addressed within the context of a randomized controlled trial.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/sj.bmt.1704087", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1096890", 
        "issn": [
          "0268-3369", 
          "1476-5365"
        ], 
        "name": "Bone Marrow Transplantation", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "31"
      }
    ], 
    "name": "Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: a prospective phase II study", 
    "pagination": "1143", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "b890d8474d92fb4d13f3441a472948ee2c45e4bc4f5d24ef921219216b072cdc"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12796794"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8702459"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bmt.1704087"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1038745224"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bmt.1704087", 
      "https://app.dimensions.ai/details/publication/pub.1038745224"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:07", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000360_0000000360/records_118344_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/1704087"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704087'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704087'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704087'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704087'


 

This table displays all metadata directly associated to this object as RDF triples.

246 TRIPLES      21 PREDICATES      76 URIs      36 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bmt.1704087 schema:about N14f640e31d4844c58bd29cc398073b42
2 N174071de58a746c2a0fa8b9052f5414d
3 N26d2cb505ca046b09a596681c9fe64f0
4 N2b1a101729a947c3a310d187dad98d03
5 N3512e0cfaba445ecbea2c6b449fd1d2f
6 N35900653bf6d4cbbac8731e16920c51e
7 N405662bd311746808b8cb33be2367827
8 N5b90242d7811458c8ab6b22020f79b00
9 N747825b6eedf41deba7aca3d50721d33
10 N901fd2eb4cd94f8caaae9274596a099b
11 Nb8cadd80c91f42a89a56298b8faa8395
12 Nc1c4ebfafcec4c3dae1585c7e19da261
13 Nc2f32f1f46ee432595325e5d0af20840
14 Ndb6b96e8fdab474da949d4495f18c426
15 Ndc796522999344e9a50db98a971bd552
16 anzsrc-for:11
17 anzsrc-for:1103
18 schema:author N90cf10f49f124f6c9eea71e85369531d
19 schema:citation sg:pub.10.1038/sj.bmt.1700895
20 sg:pub.10.1038/sj.bmt.1702717
21 https://app.dimensions.ai/details/publication/pub.1075452537
22 https://app.dimensions.ai/details/publication/pub.1076117384
23 https://app.dimensions.ai/details/publication/pub.1076351056
24 https://app.dimensions.ai/details/publication/pub.1077047096
25 https://app.dimensions.ai/details/publication/pub.1078733315
26 https://app.dimensions.ai/details/publication/pub.1082494583
27 https://app.dimensions.ai/details/publication/pub.1082764184
28 https://app.dimensions.ai/details/publication/pub.1082902670
29 https://app.dimensions.ai/details/publication/pub.1083343944
30 https://doi.org/10.1002/bjs.1800750920
31 https://doi.org/10.1002/hep.1840040121
32 https://doi.org/10.1002/hep.1840190515
33 https://doi.org/10.1016/s0022-5347(17)41145-1
34 https://doi.org/10.1046/j.1365-2141.1999.01680.x
35 https://doi.org/10.1055/s-0038-1642757
36 https://doi.org/10.1056/nejm199505183322003
37 https://doi.org/10.1056/nejm199603143341102
38 https://doi.org/10.1080/01621459.1958.10501452
39 https://doi.org/10.1097/00007890-198706000-00020
40 https://doi.org/10.1097/00007890-198712000-00011
41 https://doi.org/10.1097/00007890-199604150-00014
42 https://doi.org/10.1111/j.1365-2141.1990.tb02583.x
43 https://doi.org/10.1111/j.1600-0609.1991.tb01859.x
44 https://doi.org/10.1161/01.cir.98.15.1575
45 https://doi.org/10.1182/blood-2001-12-0159
46 https://doi.org/10.1182/blood-2002-04-1216
47 https://doi.org/10.1200/jco.1988.6.10.1562
48 https://doi.org/10.1200/jco.1990.8.10.1699
49 https://doi.org/10.7326/0003-4819-118-4-199302150-00003
50 https://doi.org/10.7326/0003-4819-128-12_part_1-199806150-00002
51 schema:datePublished 2003-06
52 schema:datePublishedReg 2003-06-01
53 schema:description We evaluated 40 patients undergoing high-dose chemo/radiotherapy (HDCT) and hematopoietic stem cell transplantation (HSCT) (allogeneic (22), autologous (18)) to determine the safety and feasibility of administering low molecular weight heparin (LMWH) as hepatic veno-occlusive disease (VOD) prophylaxis. Patients received a once daily subcutaneous injection of dalteparin 2500 anti-Xa i.u. commencing the day prior to starting HDCT, and continuing until day +30 post HSCT or hospital discharge, whichever came first. Dosage adjustments were made for patients developing renal failure. All bleeding episodes were recorded and graded and VOD was diagnosed and graded according to Seattle criteria. At 100 days of follow-up, the overall survival and probability of regimen-related mortality were 85 and 15%, respectively. Nine patients developed VOD. The probability of developing VOD post allogeneic and autologous HSCT was 28% (95% CI, 6-45) and 17% (95% CI, 0-32), respectively. VOD was graded as moderate (n=8) and severe (n=1). VOD resolved in all cases except for one patient who died secondary to severe VOD and multiorgan failure. Clinically significant bleeding episodes occurred in three patients; 24 patients developed minor bleeding not requiring specific therapy. All bleeding episodes resolved. These results suggest that LMWH for VOD prophylaxis is safe with a low incidence of serious bleeding events. Whether it is superior to unfractionated heparin, however, is unknown and should be addressed within the context of a randomized controlled trial.
54 schema:genre research_article
55 schema:inLanguage en
56 schema:isAccessibleForFree true
57 schema:isPartOf Ne8308833203a47f6a9f58425a910bdb7
58 Nfdbb05a5307e4146b0bc3e0271b1d032
59 sg:journal.1096890
60 schema:name Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: a prospective phase II study
61 schema:pagination 1143
62 schema:productId N04fe2c5504d94515a0760931b80f9001
63 N2985ea9cca594e3487824f7c638b8ce4
64 N3266abe1f5b54497b4ad5d38a29a8785
65 Nd39f6d10ebbb4a9bbb81881d5a2662fb
66 Nd4ae4014332a4b0d8850de0d3ed5400d
67 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038745224
68 https://doi.org/10.1038/sj.bmt.1704087
69 schema:sdDatePublished 2019-04-11T12:07
70 schema:sdLicense https://scigraph.springernature.com/explorer/license/
71 schema:sdPublisher Nd77a6feb66fd4d338db44b181edd03d8
72 schema:url https://www.nature.com/articles/1704087
73 sgo:license sg:explorer/license/
74 sgo:sdDataset articles
75 rdf:type schema:ScholarlyArticle
76 N04fe2c5504d94515a0760931b80f9001 schema:name doi
77 schema:value 10.1038/sj.bmt.1704087
78 rdf:type schema:PropertyValue
79 N14f640e31d4844c58bd29cc398073b42 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Prospective Studies
81 rdf:type schema:DefinedTerm
82 N174071de58a746c2a0fa8b9052f5414d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Hematopoietic Stem Cell Transplantation
84 rdf:type schema:DefinedTerm
85 N26d2cb505ca046b09a596681c9fe64f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Middle Aged
87 rdf:type schema:DefinedTerm
88 N2985ea9cca594e3487824f7c638b8ce4 schema:name dimensions_id
89 schema:value pub.1038745224
90 rdf:type schema:PropertyValue
91 N2b1a101729a947c3a310d187dad98d03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Female
93 rdf:type schema:DefinedTerm
94 N3266abe1f5b54497b4ad5d38a29a8785 schema:name pubmed_id
95 schema:value 12796794
96 rdf:type schema:PropertyValue
97 N3512e0cfaba445ecbea2c6b449fd1d2f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Adolescent
99 rdf:type schema:DefinedTerm
100 N35900653bf6d4cbbac8731e16920c51e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Hemorrhage
102 rdf:type schema:DefinedTerm
103 N3827b6d4f4214e5f8c5c3eb528347ec2 schema:affiliation https://www.grid.ac/institutes/grid.55602.34
104 schema:familyName Dorcas
105 schema:givenName V G
106 rdf:type schema:Person
107 N3d91c51ef8e241f59cdfbb3a37dab2d5 schema:affiliation N7191c10f2b16468b9b3982cefc08a52e
108 schema:familyName Pierce
109 schema:givenName R
110 rdf:type schema:Person
111 N405662bd311746808b8cb33be2367827 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Adult
113 rdf:type schema:DefinedTerm
114 N5b90242d7811458c8ab6b22020f79b00 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Transplantation, Homologous
116 rdf:type schema:DefinedTerm
117 N60648fde19864632965250b146d84710 rdf:first N3d91c51ef8e241f59cdfbb3a37dab2d5
118 rdf:rest rdf:nil
119 N65b2ed2374f543a29805b164f3f67fc4 rdf:first sg:person.0601741326.32
120 rdf:rest N60648fde19864632965250b146d84710
121 N7191c10f2b16468b9b3982cefc08a52e schema:name Pharmacia Canada, Mississauga, Ont., Canada
122 rdf:type schema:Organization
123 N747825b6eedf41deba7aca3d50721d33 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Dalteparin
125 rdf:type schema:DefinedTerm
126 N7514c8aaad4d4839b67d0d873649cf6c rdf:first N3827b6d4f4214e5f8c5c3eb528347ec2
127 rdf:rest N65b2ed2374f543a29805b164f3f67fc4
128 N901fd2eb4cd94f8caaae9274596a099b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Male
130 rdf:type schema:DefinedTerm
131 N90cf10f49f124f6c9eea71e85369531d rdf:first sg:person.014626371612.16
132 rdf:rest Nf47c3fe5101a4a1d978972e5e5f5bad5
133 Nb8cadd80c91f42a89a56298b8faa8395 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Safety
135 rdf:type schema:DefinedTerm
136 Nc1c4ebfafcec4c3dae1585c7e19da261 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Humans
138 rdf:type schema:DefinedTerm
139 Nc2f32f1f46ee432595325e5d0af20840 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Injections, Subcutaneous
141 rdf:type schema:DefinedTerm
142 Nd39f6d10ebbb4a9bbb81881d5a2662fb schema:name nlm_unique_id
143 schema:value 8702459
144 rdf:type schema:PropertyValue
145 Nd4ae4014332a4b0d8850de0d3ed5400d schema:name readcube_id
146 schema:value b890d8474d92fb4d13f3441a472948ee2c45e4bc4f5d24ef921219216b072cdc
147 rdf:type schema:PropertyValue
148 Nd77a6feb66fd4d338db44b181edd03d8 schema:name Springer Nature - SN SciGraph project
149 rdf:type schema:Organization
150 Ndb6b96e8fdab474da949d4495f18c426 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Hepatic Veno-Occlusive Disease
152 rdf:type schema:DefinedTerm
153 Ndc796522999344e9a50db98a971bd552 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Transplantation, Autologous
155 rdf:type schema:DefinedTerm
156 Ne8308833203a47f6a9f58425a910bdb7 schema:volumeNumber 31
157 rdf:type schema:PublicationVolume
158 Nf47c3fe5101a4a1d978972e5e5f5bad5 rdf:first sg:person.01063571465.14
159 rdf:rest N7514c8aaad4d4839b67d0d873649cf6c
160 Nfdbb05a5307e4146b0bc3e0271b1d032 schema:issueNumber 12
161 rdf:type schema:PublicationIssue
162 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
163 schema:name Medical and Health Sciences
164 rdf:type schema:DefinedTerm
165 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
166 schema:name Clinical Sciences
167 rdf:type schema:DefinedTerm
168 sg:journal.1096890 schema:issn 0268-3369
169 1476-5365
170 schema:name Bone Marrow Transplantation
171 rdf:type schema:Periodical
172 sg:person.01063571465.14 schema:affiliation https://www.grid.ac/institutes/grid.55602.34
173 schema:familyName Thompson
174 schema:givenName K
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01063571465.14
176 rdf:type schema:Person
177 sg:person.014626371612.16 schema:affiliation https://www.grid.ac/institutes/grid.55602.34
178 schema:familyName Forrest
179 schema:givenName D L
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014626371612.16
181 rdf:type schema:Person
182 sg:person.0601741326.32 schema:affiliation https://www.grid.ac/institutes/grid.55602.34
183 schema:familyName Couban
184 schema:givenName S H
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601741326.32
186 rdf:type schema:Person
187 sg:pub.10.1038/sj.bmt.1700895 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022546807
188 https://doi.org/10.1038/sj.bmt.1700895
189 rdf:type schema:CreativeWork
190 sg:pub.10.1038/sj.bmt.1702717 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041342887
191 https://doi.org/10.1038/sj.bmt.1702717
192 rdf:type schema:CreativeWork
193 https://app.dimensions.ai/details/publication/pub.1075452537 schema:CreativeWork
194 https://app.dimensions.ai/details/publication/pub.1076117384 schema:CreativeWork
195 https://app.dimensions.ai/details/publication/pub.1076351056 schema:CreativeWork
196 https://app.dimensions.ai/details/publication/pub.1077047096 schema:CreativeWork
197 https://app.dimensions.ai/details/publication/pub.1078733315 schema:CreativeWork
198 https://app.dimensions.ai/details/publication/pub.1082494583 schema:CreativeWork
199 https://app.dimensions.ai/details/publication/pub.1082764184 schema:CreativeWork
200 https://app.dimensions.ai/details/publication/pub.1082902670 schema:CreativeWork
201 https://app.dimensions.ai/details/publication/pub.1083343944 schema:CreativeWork
202 https://doi.org/10.1002/bjs.1800750920 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003319436
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1002/hep.1840040121 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001684792
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1002/hep.1840190515 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024503731
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1016/s0022-5347(17)41145-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090323469
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1046/j.1365-2141.1999.01680.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1011972675
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1055/s-0038-1642757 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079418729
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1056/nejm199505183322003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006959942
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1056/nejm199603143341102 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033022107
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1080/01621459.1958.10501452 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058299418
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1097/00007890-198706000-00020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011021768
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1097/00007890-198712000-00011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046507280
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1097/00007890-199604150-00014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060275812
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1111/j.1365-2141.1990.tb02583.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1039154419
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1111/j.1600-0609.1991.tb01859.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1027570453
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1161/01.cir.98.15.1575 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030465788
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1182/blood-2001-12-0159 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039448350
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1182/blood-2002-04-1216 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003577261
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1200/jco.1988.6.10.1562 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079525316
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1200/jco.1990.8.10.1699 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078482794
239 rdf:type schema:CreativeWork
240 https://doi.org/10.7326/0003-4819-118-4-199302150-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073697190
241 rdf:type schema:CreativeWork
242 https://doi.org/10.7326/0003-4819-128-12_part_1-199806150-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073701918
243 rdf:type schema:CreativeWork
244 https://www.grid.ac/institutes/grid.55602.34 schema:alternateName Dalhousie University
245 schema:name The Bone Marrow Transplantation Program of Atlantic Canada, Division of Hematology, Department of Medicine, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada
246 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...